Regulators set to deepen transatlantic ties
by Gary Finnegan: Medicines watchdogs on both sides of the Atlantic could significantly step up collaboration if a new transatlantic trade deal is sewn up later this year.
by Gary Finnegan: Medicines watchdogs on both sides of the Atlantic could significantly step up collaboration if a new transatlantic trade deal is sewn up later this year.
by Bruce Sylvester: Researchers report that a combination morphine and nortriptyline successfully relieves chronic neuropathic pain in 87 per cent of patients, and the efficacy of the combination… read more.
by Bruce Sylvester: Paracetamol is not effective for treating neck and lower back pain, and it provides only slight relief for osteoarthritis, researchers reported on March 31, 2015… read more.
Medicine obviously can’t do much good if it sits on a pharmacy shelf. Yet more than one-quarter of the acne patients surveyed by researchers didn’t get medications prescribed… read more.
by Bruce Sylvester: Researchers report that treating post-tonsillectomy pain with morphine can cause some children to develop life-threatening respiratory problems. The study also showed that ibuprofen is a… read more.
by Gary Finnegan: The number of new medicines for rare diseases approved by EU drug regulators hit a record high in 2014. Of the 82 medicines given the… read more.
by Gary Finnegan: The European Medicines Agency (EMA) is to step up international cooperation on regulating generics. The regulator says it is ready to share assessment reports for… read more.
by Gary Finnegan: An electronic repository for periodic safety update reports (PSURs) and their assessment reports has been launched by the European Medicines Agency (EMA).
by Gary Finnegan: Seven new medicines have approved at the January meeting of the Committee for Medicinal Products for Human Use (CHMP) – the European Medicines Agency’s influential… read more.
by Bruce Sylvester: In the non-cardiac surgical setting, neither aspirin nor clonidine taken perioperatively appears to reduce the risk of acute kidney injury, researchers reported on Nov. 15,… read more.
by Gary Finnegan: The European Medicines Agency (EMA) has recommended 10 new medicines for approval, taking the total approvals for 2014 to 75 with one additional meeting still… read more.
by Gary Finnegan: The European Medicines Agency finds itself, not for the first time, entering a new year surrounded by uncertainty over the future of its leadership.
Advertisment